BioMed Research International / 2015 / Article / Fig 1

Research Article

Osteoarticular Expression of Musashi-1 in an Experimental Model of Arthritis

Figure 1

TNFα-blocker administration attenuates clinical CIA. Clinical scores in mice with CIA intraperitoneally treated from day 25 after immunization with PBS (control, C-group, closed squares) or TNFα-blocker (2 mg/week, E-group, open circles) once per week for four weeks. Values are the mean ± SD of 20 mice per group. Differences were significant at (asterisks) for E-group versus C-group at indicated time points.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.